Skip to main content
14th Annual Conference on Litigating Class Actions

14th Annual Conference on Litigating Class Actions

14th Annual Conference on Litigating Class Actions

Presented By: Law Seminars International

About the Event

Trends, tips and strategies from the Nation’s leading class action experts.

Key developments in class actions continued in 2017, with important cases involving cybersecurity, privacy, the Internet of Things, labor and employment, corporate acquisitions and securities, consumer protection, pharmaceuticals, and government investigations. Many court rulings emerged in these cases on legal issues such as Article III standing, arbitration clauses with class-action waivers, ascertainability, commonality, predominance, statistical evidence, appellate review, and settlements. Lower courts continue to interpret and apply opinions from the U.S. Supreme Court in cases such as Comcast, Concepcion, Dukes, Genesis Healthcare, Halliburton, and Spokeo. The Trump Administration, a Republican-controlled Congress, and revisions to the Federal Rules of Civil Procedure will bring further changes to class actions, yet these cases continue to proliferate with uncertain and mixed results. Please join us for this program covering important developments in class actions, with presentations demonstrating that such cases remain a lively area of law.

Credit

This program qualifies for 11.00 (including 1 ethics) Washington CLE credits.

Date / Time

May 10 - 11, 2018

Thursday, May 10, 2018
8:00 AM - 5:00 PM

Friday, May 11, 2018
9:00 AM - 3:00 PM

Location

1201 Third Avenue Building
Seattle, WA 98101

 

Learn More & Register Now >>

 


 

JAMS Featured Speakers

Speaker

Topic

Hon. Thomas McPhee (Ret.)

Settlement Strategies for Class Actions and Multidistrict Litigation
Friday, May 11, 2018 | 2:30 PM - 3:30PM

Best practices for designing a settlement that the courts will approve; when not in court, adapting strategies for maximum success in ADR; tips for more effectively administering settlements once approved.

Scroll to top